共 50 条
- [31] Results of a phase I trial of the proteasome inhibitor carfilzomib in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and small lymphocytic leukemia (SLL).JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Woyach, Jennifer Ann论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAFlynn, Joseph M.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAJones, Jeffrey Alan论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAAndritsos, Leslie A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USALucas, Margaret论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAChase, Weihong论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAYang, Ying论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USALucas, David M.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USASass, Ellen论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAWaymer, Sharon论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USALing, Yonghua论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAJiang, Yao论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAPhelps, Mitch A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAByrd, John C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USA
- [32] Outcomes of first-line treatment for chronic lymphocytic leukemia (CLL) with 17p deletion (del17p)JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)Strati, Paolo论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAKeating, Michael J.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAO'Brien, Susan Mary论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFerrajoli, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USABurger, Jan Andreas论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAFaderl, Stefan论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAJain, Nitin论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USAWierda, William G.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
- [33] Zanubrutinib in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma: final results and correlative analysis of lymphocytosisLEUKEMIA & LYMPHOMA, 2023, 64 (03) : 712 - 716Xu, Wei论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaYang, Shenmiao论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peking Univ Peoples Hosp, Inst Hematol, Beijing, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaZhou, Keshu论文数: 0 引用数: 0 h-index: 0机构: Zhengzhou Univ, Henan Canc Hosp, Affiliated Canc Hosp, Zhengzhou, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaPan, Ling论文数: 0 引用数: 0 h-index: 0机构: Sichuan Univ, West China Hosp, Chengdu, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaLi, Zengjun论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaGao, Sujun论文数: 0 引用数: 0 h-index: 0机构: First Hosp Jilin Univ, Changchun, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaZhou, Daobin论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Beijing, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaHu, Jianda论文数: 0 引用数: 0 h-index: 0机构: Fujian Med Univ Union Hosp, Fujian Inst Hematol, Fujian Prov Key Lab Hematol, Fuzhou, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaFeng, Ru论文数: 0 引用数: 0 h-index: 0机构: Southern Med Univ, Nanfang Hosp, Guangzhou, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaHuang, Haiwen论文数: 0 引用数: 0 h-index: 0机构: Soochow Univ, Hosp 1, Suzhou, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaWang, Tingyu论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaLi, Dengju论文数: 0 引用数: 0 h-index: 0机构: Tongji Med Coll, Tongji Hosp, Wuhan, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaJi, Meng论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Beijing, Peoples R China BeiGene Shanghai Co Ltd, Shanghai, Peoples R China BeiGene USA Inc, San Mateo, CA USA Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaGuo, Haiyi论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Beijing, Peoples R China BeiGene Shanghai Co Ltd, Shanghai, Peoples R China BeiGene USA Inc, San Mateo, CA USA Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaZhao, Xia论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Beijing, Peoples R China BeiGene Shanghai Co Ltd, Shanghai, Peoples R China BeiGene USA Inc, San Mateo, CA USA Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaWu, Binghao论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Beijing, Peoples R China BeiGene Shanghai Co Ltd, Shanghai, Peoples R China BeiGene USA Inc, San Mateo, CA USA Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaYu, Yiling论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Beijing, Peoples R China BeiGene Shanghai Co Ltd, Shanghai, Peoples R China BeiGene USA Inc, San Mateo, CA USA Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaWang, Yu论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Beijing, Peoples R China BeiGene Shanghai Co Ltd, Shanghai, Peoples R China BeiGene USA Inc, San Mateo, CA USA Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaHuang, Jane论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Beijing, Peoples R China BeiGene Shanghai Co Ltd, Shanghai, Peoples R China BeiGene USA Inc, San Mateo, CA USA Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaNovotny, William论文数: 0 引用数: 0 h-index: 0机构: BeiGene Beijing Co Ltd, Beijing, Peoples R China BeiGene Shanghai Co Ltd, Shanghai, Peoples R China BeiGene USA Inc, San Mateo, CA USA Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R ChinaLi, Jianyong论文数: 0 引用数: 0 h-index: 0机构: Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R China Nanjing Med Univ, Jiangsu Prov Hosp, Collaborat Innovat Ctr Personalized Canc Med, Dept Hematol,Affiliated Hosp 1, Nanjing, Peoples R China
- [34] A phase I trial of the intravenous Hsp90 inhibitor alvespimycin (17-DMAG) in patients with relapsed chronic lymphocytic leukemia/small lymphocytic lymphomaLEUKEMIA & LYMPHOMA, 2016, 57 (09) : 2212 - 2215Maddocks, Kami论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USAHertlein, Erin论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USAChen, Timothy L.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USAWagner, Amy J.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USALing, Yonghua论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Coll Pharm, Div Pharmaceut, 500 W 12Th Ave, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USAFlynn, Joseph论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA论文数: 引用数: h-index:机构:Johnson, Amy J.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USAByrd, John C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Med Chem, 500 W 12Th Ave, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USAJones, Jeffrey A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA
- [35] A PHASE 2 STUDY OF THE BTK INHIBITOR IBRUTINIB IN GENETIC RISK-STRATIFIED RELAPSED AND REFRACTORY PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL)HAEMATOLOGICA, 2014, 99 : 522 - 522论文数: 引用数: h-index:机构:Flynn, J. M.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAAndritsos, L. A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAAwan, F.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAWoyach, J. A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAGrever, M. R.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAStefanos, M.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USALynch, J.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USA论文数: 引用数: h-index:机构:Byrd, J. C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USAJones, J. A.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Columbus, OH 43210 USA Ohio State Univ, Columbus, OH 43210 USA
- [36] Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)Annals of Hematology, 2017, 96 : 1577 - 1578Marcelo Pitombeira de Lacerda论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de HematologiaNayara Ribeiro Guedes论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de HematologiaPatricia Eiko Yamakawa论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de HematologiaAndre Domingues Pereira论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de HematologiaAna Rita Brito Medeiros da Fonseca论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de HematologiaMaria Lourdes Lopes Ferrari de Chauffaille论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de HematologiaMatheus Vescovi Goncalves论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de HematologiaMihoko Yamamoto论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de HematologiaCelso Arrais Rodrigues论文数: 0 引用数: 0 h-index: 0机构: Universidade Federal de São Paulo (UNIFESP),Disciplina de Hematologia
- [37] Treatment of refractory autoimmune hemolytic anemia with venetoclax in relapsed chronic lymphocytic leukemia with del(17p)ANNALS OF HEMATOLOGY, 2017, 96 (09) : 1577 - 1578de Lacerda, Marcelo Pitombeira论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, BrazilGuedes, Nayara Ribeiro论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, BrazilYamakawa, Patricia Eiko论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, BrazilPereira, Andre Domingues论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, BrazilMedeiros da Fonseca, Ana Rita Brito论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, BrazilLopes Ferrari de Chauffaille, Maria Lourdes论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, BrazilGoncalves, Matheus Vescovi论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, BrazilYamamoto, Mihoko论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, BrazilRodrigues, Celso Arrais论文数: 0 引用数: 0 h-index: 0机构: Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil Univ Fed Sao Paulo, UNIFESP, Disciplina Hematol, R Diogo de Faria 824, Sao Paulo, Brazil
- [38] Health-related quality of life outcomes associated with zanubrutinib versus ibrutinib monotherapy in patients with relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: results from the ALPINE TrialCURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (11) : 1497 - 1503Tam, Constantine S.论文数: 0 引用数: 0 h-index: 0机构: Alfred Hlth, Melbourne, Australia Monash Univ, Melbourne, Australia Alfred Hlth, Melbourne, AustraliaLamanna, Nicole论文数: 0 引用数: 0 h-index: 0机构: Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY USA Alfred Hlth, Melbourne, AustraliaO'Brien, Susan M.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA Alfred Hlth, Melbourne, AustraliaQiu, Lugui论文数: 0 引用数: 0 h-index: 0机构: Inst Hematol, Natl Clin Res Ctr Blood Dis, State Key Lab Expt Hematol, Tianjin, Peoples R China Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, Tianjin, Peoples R China Alfred Hlth, Melbourne, AustraliaYang, Keri论文数: 0 引用数: 0 h-index: 0机构: Beigene USA Inc, San Mateo, CA USA Alfred Hlth, Melbourne, AustraliaBarnes, Gisoo论文数: 0 引用数: 0 h-index: 0机构: Beigene USA Inc, San Mateo, CA USA Alfred Hlth, Melbourne, AustraliaWu, Ken论文数: 0 引用数: 0 h-index: 0机构: Beigene USA Inc, San Mateo, CA USA Alfred Hlth, Melbourne, AustraliaSalmi, Tommi论文数: 0 引用数: 0 h-index: 0机构: BeiGene Switzerland GmbH, Basel, Switzerland Alfred Hlth, Melbourne, AustraliaBrown, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Dept Med Oncol, Boston, MA USA Dana Farber Canc Inst, Dept Med Oncol, 450 Brookline Ave, Boston, MA 02215 USA Alfred Hlth, Melbourne, Australia
- [39] Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 studyCANCER MEDICINE, 2018, 7 (04): : 1043 - 1055Huang, Xiaojun论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaQiu, Lugui论文数: 0 引用数: 0 h-index: 0机构: Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, Tianjin, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaJin, Jie论文数: 0 引用数: 0 h-index: 0机构: Zhejiang Univ, Affiliated Hosp 1, Coll Med, Hangzhou, Zhejiang, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaZhou, Daobin论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll Hosp, Beijing, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaChen, Xiequn论文数: 0 引用数: 0 h-index: 0机构: Xijing Hosp, Xian, Shanxi, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaHou, Ming论文数: 0 引用数: 0 h-index: 0机构: Shandong Univ, Qilu Hosp, Jinan, Shandong, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaHu, Jianda论文数: 0 引用数: 0 h-index: 0机构: Fujian Med Univ, Union Hosp, Fuzhou, Fujian, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaHu, Yu论文数: 0 引用数: 0 h-index: 0机构: Wuhan Union Hosp, Wuhan, Hubei, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaKe, Xiaoyan论文数: 0 引用数: 0 h-index: 0机构: Peking Univ, Hosp 3, Beijing, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaLi, Junmin论文数: 0 引用数: 0 h-index: 0机构: Ruijin Hosp, Shanghai, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaLiang, Yingmin论文数: 0 引用数: 0 h-index: 0机构: Tangdu Hosp, Xian, Shanxi, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaLiu, Ting论文数: 0 引用数: 0 h-index: 0机构: West China Hosp, Chengdu, Sichuan, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaLv, Yue论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaRen, Hanyun论文数: 0 引用数: 0 h-index: 0机构: Peking Union Med Coll Hosp, Beijing, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaSun, Aining论文数: 0 引用数: 0 h-index: 0机构: Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaWang, Jianmin论文数: 0 引用数: 0 h-index: 0机构: Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaZhao, Chunting论文数: 0 引用数: 0 h-index: 0机构: Qingdao Univ, Med Coll, Affiliated Hosp, Qingdao, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaSalman, Mariya论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Raritan, NJ USA Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaSun, Steven论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, Raritan, NJ USA Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaHowes, Angela论文数: 0 引用数: 0 h-index: 0机构: Janssen Res & Dev, High Wycombe, Bucks, England Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaWang, Jingzhao论文数: 0 引用数: 0 h-index: 0机构: Janssen China Res & Dev Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaWu, Peng论文数: 0 引用数: 0 h-index: 0机构: Janssen China Res & Dev Ctr, Beijing, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R ChinaLi, Jianyong论文数: 0 引用数: 0 h-index: 0机构: Jiangsu Prov Hosp, Nanjing, Jiangsu, Peoples R China Peking Univ, Peoples Hosp, 11 Xizhimen South St, Beijing 100044, Peoples R China
- [40] Autoimmune Hemolytic Anemia and Immune Mediated Thrombocytopenia in the Phase III RESONATE™ Study of Ibrutinib Vs Ofatumumab in Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Including a Case ReportBLOOD, 2014, 124 (21)Montillo, Marco论文数: 0 引用数: 0 h-index: 0机构: Osped Niguarda Ca Granda, Milan, Italy Osped Niguarda Ca Granda, Milan, ItalyO'Brien, Susan论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA Osped Niguarda Ca Granda, Milan, ItalyTedeschi, Alessandra论文数: 0 引用数: 0 h-index: 0机构: Osped Niguarda Ca Granda, Milan, Italy Osped Niguarda Ca Granda, Milan, ItalyHillmen, Peter论文数: 0 引用数: 0 h-index: 0机构: Leeds Teaching Hosp, St James Inst Oncol, Leeds, W Yorkshire, England Osped Niguarda Ca Granda, Milan, ItalyDearden, Claire论文数: 0 引用数: 0 h-index: 0机构: Royal Marsden Hosp, London SW3 6JJ, England Osped Niguarda Ca Granda, Milan, ItalyGill, Devinder论文数: 0 引用数: 0 h-index: 0机构: Princess Alexandra Hosp, Brisbane, Qld 4102, Australia Osped Niguarda Ca Granda, Milan, ItalyBrown, Jennifer R.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Boston, MA 02115 USA Osped Niguarda Ca Granda, Milan, ItalyBarrientos, Jaqueline C.论文数: 0 引用数: 0 h-index: 0机构: North Shore LIJ Canc Inst, Lake Success, NY USA Osped Niguarda Ca Granda, Milan, ItalyMulligan, Stephen论文数: 0 引用数: 0 h-index: 0机构: Royal N Shore Hosp, Sydney, NSW, Australia Osped Niguarda Ca Granda, Milan, ItalyFurman, Richard R.论文数: 0 引用数: 0 h-index: 0机构: New York Presbyterian Hosp, Weill Cornell Med Coll, New York, NY USA Osped Niguarda Ca Granda, Milan, ItalyCymbalista, Florence论文数: 0 引用数: 0 h-index: 0机构: Hop Avicenne, Paris, France Osped Niguarda Ca Granda, Milan, ItalyPlascencia, Clara论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics Inc, Sunnyvale, CA USA Osped Niguarda Ca Granda, Milan, ItalyChang, Stephen论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics Inc, Sunnyvale, CA USA Osped Niguarda Ca Granda, Milan, ItalyHsu, Emily论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics Inc, Sunnyvale, CA USA Osped Niguarda Ca Granda, Milan, ItalyJames, Danelle F.论文数: 0 引用数: 0 h-index: 0机构: Pharmacyclics Inc, Sunnyvale, CA USA Osped Niguarda Ca Granda, Milan, ItalyByrd, John C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Med Ctr, Columbus, OH 43210 USA Osped Niguarda Ca Granda, Milan, Italy